Learn About Nephrotic Syndrome

What is the definition of Nephrotic Syndrome?

Nephrotic syndrome is a group of symptoms and abnormal test results that include protein in the urine, low blood protein levels in the blood, high cholesterol levels, high triglyceride levels, increased blood clot risk, and swelling.

What are the alternative names for Nephrotic Syndrome?

Nephrosis

What are the causes of Nephrotic Syndrome?

Nephrotic syndrome is caused by different disorders that damage the kidneys. This damage leads to the release of too much protein in the urine.

The most common cause in children is minimal change disease. Membranous glomerulonephritis is the most common cause in adults. In both diseases, the glomeruli in the kidneys are damaged. Glomeruli are the structures that help filter wastes and fluids.

This condition can also occur due to:

  • Cancer
  • Diseases such as diabetes, systemic lupus erythematosus, multiple myeloma, and amyloidosis
  • Genetic disorders
  • Immune disorders
  • Infections (such as strep throat, hepatitis, or mononucleosis)
  • Use of certain drugs

It can occur with kidney disorders such as:

  • Focal and segmental glomerulosclerosis
  • Glomerulonephritis
  • Mesangiocapillary glomerulonephritis

Nephrotic syndrome can affect all age groups. In children, it is most common between ages 2 and 6. This disorder occurs slightly more often in males than females.

What are the symptoms of Nephrotic Syndrome?

Swelling (edema) is the most common symptom. It may occur:

  • In the face and around the eyes (facial swelling)
  • In the arms and legs, especially in the feet and ankles
  • In the belly area (swollen abdomen)

Other symptoms include:

  • Skin rash or sores
  • Foamy appearance of the urine
  • Poor appetite
  • Weight gain (unintentional) from fluid retention
  • Seizures
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Nephrotic Syndrome?

The goals of treatment are to relieve symptoms, prevent complications, and delay kidney damage. To control nephrotic syndrome, the disorder that is causing it must be treated. You may need treatment for life.

Treatments may include any of the following:

  • Keeping blood pressure at or below 130/80 mm Hg to delay kidney damage. Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) are the medicines most often used. ACE inhibitors and ARBs may also help decrease the amount of protein lost in the urine.
  • Corticosteroids and other drugs that suppress or quiet the immune system.
  • Treating high cholesterol to reduce the risk for heart and blood vessel problems -- A low-fat, low-cholesterol diet is usually not enough for people with nephrotic syndrome. Medicines to reduce cholesterol and triglycerides (usually statins) may be needed.
  • A low-sodium diet may help with swelling in the hands and legs. Water pills (diuretics) may also help with this problem.
  • Low-protein diets may be helpful. Your provider may suggest a moderate-protein diet (1 gram of protein per kilogram of body weight per day).
  • Taking vitamin D supplements if nephrotic syndrome is long-term and is not responding to treatment.
  • Taking blood thinner drugs to treat or prevent blood clots.
Who are the top Nephrotic Syndrome Local Doctors?

Southern California Permanente Medical Group

5601 De Soto Ave, 
Woodland Hills, CA 
 (0.9 mi)
Languages Spoken:
English

Gbemisola Adenuga is a Nephrologist in Woodland Hills, California. Dr. Adenuga and is rated as an Experienced provider by MediFind in the treatment of Nephrotic Syndrome. Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Chronic Kidney Disease, and Acute Kidney Failure.

Internal Medicine
Internal Medicine
7345 Medical Ctr Dr, Suite 160, 
West Hills, CA 
 (4.0 mi)
Languages Spoken:
English
Offers Telehealth

Marc Lavin is an Internal Medicine provider in West Hills, California. Dr. Lavin and is rated as an Experienced provider by MediFind in the treatment of Nephrotic Syndrome. His top areas of expertise are Diffuse Mesangial Sclerosis, Frasier Syndrome, Denys-Drash Syndrome (DDS), and Focal Segmental Glomerulosclerosis.

 
 
 
 
Learn about our expert tiers
Learn More
Shilpa Sayana
Internal Medicine
Internal Medicine
14006 Riverside Dr, Suite 18, 
Sherman Oaks, CA 
 (9.7 mi)
Experience:
21+ years
Languages Spoken:
English
Offers Telehealth

Shilpa Sayana is an Internal Medicine provider in Sherman Oaks, California. Dr. Sayana has been practicing medicine for over 21 years and is rated as an Experienced provider by MediFind in the treatment of Nephrotic Syndrome. Her top areas of expertise are Irritable Bowel Syndrome (IBS), Homocystinuria due to MTHFR Deficiency, Gas Bloat Syndrome, and Obesity in Children.

What is the outlook (prognosis) for Nephrotic Syndrome?

The outcome varies. Some people recover from the condition. Others develop long-term kidney disease and need dialysis and eventually a kidney transplant.

What are the possible complications of Nephrotic Syndrome?

Health problems that may result from nephrotic syndrome include:

  • Acute kidney failure
  • Hardening of the arteries and related heart diseases
  • Chronic kidney disease
  • Fluid overload, heart failure, fluid buildup in lungs
  • Infections, including pneumococcal pneumonia
  • Malnutrition
  • Renal vein thrombosis
When should I contact a medical professional for Nephrotic Syndrome?

Contact your provider if:

  • You or your child develops symptoms of nephrotic syndrome, including swelling in face, belly, or arms and legs, or skin sores
  • You or your child are being treated for nephrotic syndrome, but symptoms don't improve
  • New symptoms develop, including cough, decreased urine output, discomfort with urination, fever, severe headache

Go to the emergency room or call the local emergency number (such as 911) if you have seizures.

How do I prevent Nephrotic Syndrome?

Treating conditions that can cause nephrotic syndrome may help prevent the syndrome.

What are the latest Nephrotic Syndrome Clinical Trials?
Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy (ITN080AI)

Background: Primary membranous nephropathy (MN) is among the most common causes of nephrotic syndrome in adults. MN affects individuals of all ages and races. The peak incidence of MN is in the fifth decade of life. Primary MN is recognized to be an autoimmune disease, a disease where the body's own immune system causes damage to kidneys. This damage can cause the loss of too much protein in the urine. Drugs ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Parallel-group Treatment, Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Umbrella Study to Evaluate the Efficacy and Safety of Frexalimab, SAR442970, and Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

Summary: This is a parallel, Phase 2a, double-blind, 6-arm study for the treatment of primary focal segmental glomerulosclerosis (FSGS) or primary minimal change disease (MCD). The purpose of this study is to measure the change in proteinuria and its impact on the rates of remission of nephrotic syndrome with frexalimab, SAR442970, or rilzabrutinib compared with placebo in participants with primary FSGS or...

Who are the sources who wrote this article ?

Published Date: August 28, 2023
Published By: Walead Latif, MD, Nephrologist and Clinical Associate Professor, Rutgers Medical School, Newark, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Erkan E. Nephrotic syndrome. In: Kliegman RM, St. Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, eds. Nelson Textbook of Pediatrics. 21st ed. Philadelphia, PA: Elsevier; 2020:chap 545.

Radhakrishnan J, Stokes MB. Glomerular disorders and nephrotic syndromes. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 107.

Saha MK, Pendergraft WF, Jennette JC, Falk RJ. Primary glomerular disease. In: Yu ASL, Chertow GM, Luyckx VA, Marsden PA, Skorecki K, Taal MW, eds. Brenner and Rector's The Kidney. 11th ed. Philadelphia, PA: Elsevier; 2020:chap 31.